References
- Koeffler HP, Golde DW. Chronic myelogenous leukemia—new concepts. N Engl J Med 1981: 304: 1201–9:1269–74
- Chromosomes in Ph1-positive chronic granulocytic leukaemia. First International Workshop on Chromosomes in Leukaemia Br J Haematol 1978: 39(3):305–9
- Canellos GP, Whang-Peng J, De Vita VT. Chronic granulocytic leukemia without the Philadelphia chromosome. Am J Clin Pathol 1976: 65(4):467–70
- Rosenthal S, Canellos GP, Whang-Peng J. et al. Blast crisis of chronic granulocytic leukemia: morphologic variants and therapeutic implications. Am J Med 197763(4):542–7
- Spiers AS. Metamorphosis of chronic granulocytic leukaemia: diagnosis, classification and management. Br J Haematol 1979: 41(1):1–7
- Theologldes A. Unfavorable signs in patients with chronic myelocytic leukemia Ann Intern Med 1972 Jan:76:95–9
- Kennedy BJ. Hydroxyurea therapy In chronic myelogenous leukemia. Cancer 1972 Apr:29:1052–6
- Bolin RW, Robinson WA. Sutheriand J, et al. Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia Cancer 1982: 50(9):1683–6
- Wolf DJ. Silver RT, Coleman M. Splenectomy in chronic myeloid leukemia Ann Intern Med 1978: 89(5 Pt 1):684–9
- McGlave PB, Arthur DC, Kim TH, et al. Successful allogeneic bone-marrow transplantation for patients in the accelerated phase of chronic granulocytic leukaemia Lancet 1982: 2(8299):625–7
- Clift RA. Buckner CD, Thomas ED, et al. Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation Lancet 1982: 2(8299):621–3
- Goldman JM. Baughan AS. McCarthy DM. et al. Marrow transplantation for patients In the chronic phase of chronic granulocytic leukaemia Lancet 1982: 2(8299):623–5
- Goldman JM, Catovsky D. Goolden AW, et al. Buffy coat autografts for patients with chronic granulocytic leukaemia In transformation. Blut 1981: 42(3):149–55
- Gahrton G, Robert KH. Chromosomal aberrations in chronic B-cell lymphocytic leukemia. Cancer Genet Cytogenet 1982: 6(2):171–81
- Conley CL. Misitl J, Lester AJ. Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine (Baltimore) 1980: 59(5)323–34
- Greene MH, Hoover RN, Fraumeni JF Jr. Subsequent cancer In patients with chronic lymphocytic leukemia—a possible immunologic mechanism. J Natl Cancer Inst 197861(2):337–40
- Rai KR. Sawitsky A. Cronkite ER. et al. Clinical staging of chronic lymphocytic leukemia Blood 1975: 46(2):219–34
- Binet JL, Alquier A. Dighiers G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis Cancer 1981: 48(1):198–206
- Sawitsky A. Rai KR. Glidewell O, et al. Comparison of dally versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia Blood 1977: 50(6):1049–59
- Oken MM, Kaplan ME. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia Cancer Treat Rep 1979: 63(3): 441–7
- Kempin S, Lee BJ 3d, Thaler HT, et al. Combination chemotherapy of advanced chronic lymphocytic leukemia; the M-2 protocol (vincristine. BCNU. cyclophosphamide, melphalan. and prednisone). Blood 198260(5):1110–21
- Johnson RE. Radiotherapy as primary treatment for chronic lymphocytic leukaemia Clin Haematol 1977: 6(1):237–44
- Bouroncle BA. Leukemic reticuloendotheliosis (hairy cell leukemia) Blood 1979: 53(3):412–36
- Hooper WC. Boss DH, Parker CL. Leukemic reticuloendotheliosls (hairy cell leukemia): a review of the evidence concerning the immunology and origin of the cell. Leuk Res 1980: 4(5):489–503
- Golomb HM, Catovsky D, Golde DW. Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med 1978: 89(5 Pt 1)677–83
- Paladine WJ, Price LM. Williams HD, et al. Hairy-cell leukemia treated with lithium. (Letter) N Engl J Med 1981: 304(20):1237–8
- Galton DA, Goldman JM. Wiltshaw E, et al. Prolymphocyte leukaemia. Br J Haematol 1974 May:27:7–23
- Hollister D Jr, Coleman M. Treatment of prolymphocytic leukemia Cancer 1982: 50(9):1687–9